1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Israel. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, Israel population was approximately at 8.4 million. The government of Israel has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Pharmaceutical market was estimated to be worth $1.75 billion in 2015 and expected to reach $2.12 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.9% over the 2008-2020 period. The medical device market was valued at $0.97 billion in 2008 and is expected to reach approximately $1.55 billion by 2020, at a projected CAGR of 4%.

These positive trends can primarily be attributed to -
- An increasing elderly population in Israel, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Israel, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Teva, Taro, Dexcel and Rekah)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Israel healthcare market

Reasons to buy

- This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Israel healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Israel healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 17
2.1 GlobalData Report Guidance 17
3 Overview of the Pharmaceutical and Medical Device Markets 18
3.1 Pharmaceutical Market 18
3.1.1 Market Overview 18
3.1.2 Pharmaceutical Exports and Imports 22
3.1.3 Supply Channels 23
3.1.4 Market Segments 23
3.1.5 Overview of Top Five Disease Areas 25
3.1.6 Major Players 26
3.2 Medical Device Market 50
3.2.1 Market Overview 50
3.2.2 Overview of Top Five Segments 53
3.2.3 Major Players 65
3.3 Market Drivers and Barriers 100
3.3.1 Drivers 100
3.3.2 Barriers 101
4 Market Access 103
4.1 Reimbursement and Payer Landscape 103
4.1.1 Overview of Healthcare System 103
4.1.2 Reimbursement Process 104
4.1.3 Overview of Insurance Providers 105
4.1.4 Patient Share in Healthcare Spending 110
4.1.5 Price Trend in Healthcare Services 112
4.1.6 Pricing Policies 113
4.2 Regulatory Landscape 113
4.2.1 Overview of Regulatory Agencies 113
4.2.2 Market Authorization Procedure for Pharmaceutical Products 116
4.2.3 Market Authorization Procedure for Medical Devices 118
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 119
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 120
4.2.6 Intellectual Property Rights 122
4.2.7 Clinical Trial Regulations 125
4.2.8 Pharmaceutical Advertising Regulations 127
4.2.9 Pharmacy Regulations 128
4.2.10 Labeling and Packaging Regulations 129
5 Country Analysis 130
5.1 Political Environment 130
5.1.1 Political Structure 130
5.1.2 Analysis of Current Political Environment 133
5.1.3 Healthcare Policy Initiatives 135
5.2 Economic Landscape 137
5.3 Economic Indicators 140
5.3.1 Gross Domestic Product 140
5.3.2 Gross National Income 145
5.3.3 Inflation 146
5.3.4 Currency Exchange Rate 148
5.3.5 Foreign Direct Investment 149
5.3.6 Foreign Exchange Reserves 150
5.3.7 Trade Balance 151
5.3.8 General Government Structural Balance 153
5.3.9 General Government Net Debt 154
5.3.10 Major Industries 155
5.4 Demographics 156
5.4.1 Population 156
5.4.2 Education and Literacy 174
5.4.3 Employment 177
5.4.4 Disease Burden 180
5.5 Healthcare Infrastructure 183
5.5.1 Healthcare Facilities 183
5.5.2 Healthcare Parameters 188
5.5.3 Environmental Health 191
5.5.4 Healthcare Personnel 193
5.6 Healthcare Expenditure 196
5.6.1 Overview 196
5.6.2 Public and Private Sector Share 198
5.6.3 Major Components of Healthcare Spending 199
5.6.4 Healthcare Expenditure by Financing Agent 200
5.6.5 Spending in Science and Technology RandD 201
5.7 Trade Associations 202
5.7.1 Pharmaceutical Association of Israel 202
5.7.2 Pharma Israel 203
5.8 Trade Fairs 204
6 Opportunities and Challenges 205
6.1 Opportunities 205
6.2 Challenges 206
7 Appendix 208
7.1 Abbreviations 208
7.2 Bibliography 211
7.3 Research Methodology 228
7.3.1 Coverage 228
7.3.2 Secondary Research 229
7.3.3 Forecasts 229
7.3.4 Expert Panel 229
7.4 Disclaimer 230


1.1 List of Tables
Table 1: Pharmaceutical Market, Israel, Revenue ($bn), 2008-2015 20
Table 2: Pharmaceutical Market, Israel, Revenue ($bn), 2016-2020 21
Table 3: Pharmaceutical Market, Israel, Exports and Imports ($bn), 2008-2015 22
Table 4: Pharmaceutical Market, Israel, Over-the-Counter Market, Revenue ($m), 2008-2015 25
Table 5: Pharmaceutical Market, Teva, Global Revenue of Major Products, 2015 28
Table 6: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2016 29
Table 7: Pharmaceutical Market, Taro, Global, Major Products, 2016 36
Table 8: Pharmaceutical Market, Dexcel, Israel, Products, 2016 42
Table 9: Pharmaceutical Market, Rekah, Israel, Products, 2016 47
Table 10: Medical Device Market, Israel, Revenue ($bn), 2008-2015 51
Table 11: Medical Device Market, Israel, Revenue ($bn), 2016-2020 52
Table 12: Medical Device Market, Israel, Revenue by Segment ($m), 2015 54
Table 13: Medical Device Market, Israel, Nephrology and Urology Devices ($m), 2008-2015 55
Table 14: Nephrology and Urology Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012 56
Table 15: Medical Device Market, Israel, In Vitro Diagnostics ($m), 2008-2015 57
Table 16: In Vitro Diagnostics, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012 58
Table 17: Medical Device Market, Israel, Cardiovascular Devices ($m), 2008-2015 59
Table 18: Cardiovascular Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2015 60
Table 19: Medical Device Market, Israel, Ophthalmic Devices ($m), 2008-2015 61
Table 20: Ophthalmic Devices, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012 62
Table 21: Medical Device Market, Israel, Drug Delivery Devices Market ($m), 2008-2015 63
Table 22: Drug Delivery Devices Market, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2012 64
Table 23: Medical Device Market, Israel, Revenue ($m) and Market Share (%) of Leading Companies, 2015 65
Table 24: Medical Device Market, Medtronic, Major Products, 2015 67
Table 25: Siemens, Global, Major Products, 2015 74
Table 26: Medical Device Market, Boston Scientific, Major Products by Revenue ($bn), 2016 80
Table 27: Roche, Global, Major Products, 2016 93
Table 28: Medical Device Market, Roche, Global, Late-Stage Pipeline, 2016 94
Table 29: Healthcare System, Israel, Contribution Rates for Insurance Based on Employment, 2014 107
Table 30: Healthcare Spending, Israel, Co-payments Cap for Chronically ill Patients, HMO, 2016 108
Table 31: Healthcare Spending, Israel, Out-of-Pocket Expenditure (%), 2008-2014 111
Table 32: Market Access, Israel, Change in Prices of Medicines (%), 2008-2015 112
Table 33: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2008-2015 141
Table 34: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2016-2020 142
Table 35: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2008-2015 143
Table 36: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2016-2020 144
Table 37: Economic Indicators, Israel, Gross National Income per Capita ($), 2008-2015 145
Table 38: Economic Indicators, Israel, Average Consumer Price Index, 2008-2015 146
Table 39: Economic Indicators, Israel, Average Consumer Price Annual Change (%), 2008-2015 147
Table 40: Economic Indicators, Israel, Currency Exchange Rate (ILS/$), 2008-2015 148
Table 41: Economic Indicators, Israel, Foreign Direct Investment ($bn), 2008-2015 149
Table 42: Economic Indicators, Israel, Foreign Exchange Reserves ($bn), 2008-2015 150
Table 43: Economic Indicators, Israel, Imports of Goods and Services ($bn), 2008-2015 151
Table 44: Economic Indicators, Israel, Exports of Goods and Services ($bn), 2008-2015 152
Table 45: Economic Indicators, Israel, Government Structural Balance ($bn), 2008-2015 153
Table 46: Economic Indicators, Israel, General Government Net Debt as Percentage of GDP (%), 2008-2015 154
Table 47: Economic Indicators, Israel, Major Industries by Revenue (%), 2014 156
Table 48: Demographics, Israel, Population (million), 2008-2015 157
Table 49: Demographics, Israel, Population (million), 2016-2020 158
Table 50: Demographics, Israel, Population, Urban and Rural Population Share (%), 2008-2015 159
Table 51: Demographics, Israel, Population, Urban and Rural Population Share (%), 2014-2020 160
Table 52: Demographics, Israel, Population Distribution by Age Group (%), 2008-2015 161
Table 53: Demographics, Israel, Population Distribution by Age Group (%), 2016-2020 162
Table 54: Demographics, Israel, Births (per 1,000 population), 2008-2014 163
Table 55: Demographics, Israel, Mortality (per 1,000 population), 2008-2014 164
Table 56: Demographics, Israel, Major Causes of Mortality, 2013 165
Table 57: Demographics, Israel, Infant Mortality (per 1,000 live births), 2008-2015 166
Table 58: Demographics, Israel, Immunization Rate (%), 2008-2014 168
Table 59: Demographics, Israel, Major Causes of Male Mortality (per 100,000 population), 2013 169
Table 60: Demographics, Israel, Major Causes of Female Mortality (per 100,000 population), 2013 171
Table 61: Demographics, Israel, Gender Ratio (M/F), 2008-2015 172
Table 62: Demographics, Israel, Life Expectancy at Birth (years), 2008-2015 173
Table 63: Demographics, Israel, Life Expectancy at Birth (years), 2016-2020 174
Table 64: Demographics, Israel, Enrollment by Level of Education (%), 2009-2014 176
Table 65: Demographics, Israel, Unemployment Rate (%), 2008-2015 178
Table 66: Demographics, Israel, Distribution of Male Employment by Occupation (%), 2014 179
Table 67: Demographics, Israel, Distribution of Female Employment by Occupation (%), 2014 180
Table 68: Demographics, Israel, Number of Reported Cases per Disease (per 1,000 population), 2009 181
Table 69: Demographics, Israel, Major Diseases, Disability-Adjusted Life Years (‘000), 2012 183
Table 70: Healthcare Infrastructure, Israel, Number of Hospital Establishments, 2008-2014 184
Table 71: Healthcare Infrastructure, Israel, Public and Private Hospitals, 2008-2014 185
Table 72: Healthcare Infrastructure, Israel, Type of Hospital Care, 2008-2014 187
Table 73: Healthcare Infrastructure, Israel, Diagnostic Equipment (per million population), 2008-2015 188
Table 74: Healthcare Infrastructure, Israel, Hospital Beds (per 1,000 population), 2008-2015 189
Table 75: Healthcare Infrastructure, Israel, Doctors (per 1,000 population), 2008-2014 190
Table 76: Healthcare Infrastructure, Israel, PM10 (µg/m3), 2008-2014 192
Table 77: Healthcare Infrastructure, Israel, Carbon Dioxide Emissions (million metric tons), 2008-2014 193
Table 78: Healthcare Infrastructure, Israel, Nurses (per 1,000 population), 2008-2014 194
Table 79: Healthcare Infrastructure, Israel, Pharmacists (per 1,000 population), 2008-2014 195
Table 80: Healthcare Infrastructure, Israel, Dentists (per 1,000 population), 2008-2014 196
Table 81: Healthcare Expenditure, Israel, Healthcare Expenditure as a Percentage of GDP (%), 2008-2015 197
Table 82: Healthcare Expenditure, Israel, Public-Private Share (%), 2008-2013 199
Table 83: Healthcare Expenditure, Israel, Primary Healthcare Expenditure by Sector (%), 2012 200
Table 84: Healthcare Expenditure, Israel, Financing Agents (%), 2010 201
Table 85: Healthcare Expenditure, Israel, GDP Expenditure on RandD in Sciences ($bn), 2008-2014 202
Table 86: Healthcare Expenditure, Israel, Major Healthcare Trade Fairs, 2014 204


1.2 List of Figures
Figure 1: Pharmaceutical Market, Israel, Revenue ($bn), 2008-2015 20
Figure 2: Pharmaceutical Market, Israel, Revenue ($bn), 2016-2020 21
Figure 3: Pharmaceutical Market, Israel, Exports and Imports ($bn), 2008-2015 22
Figure 4: Pharmaceutical Market, Israel, Over-the-Counter Market, Revenue ($m), 2008-2015 24
Figure 5: Medical Device Market, Israel, Revenue ($bn), 2008-2015 51
Figure 6: Medical Device Market, Israel, Revenue ($bn), 2016-2020 52
.Figure 7: Medical Device Market, Israel, Revenue by Segment ($m), 2015 53
Figure 8: Medical Device Market, Israel, Nephrology and Urology Devices ($m), 2008-2015 55
Figure 9: Nephrology and Urology Devices, Israel, Market Share of Leading Companies (%), 2012 56
Figure 10: Medical Device Market, Israel, In Vitro Diagnostics ($m), 2008-2015 57
Figure 11 In Vitro Diagnostics, Israel, Market Share of Leading Companies (%), 2012 58
Figure 12: Medical Device Market, Israel, Cardiovascular Devices ($m), 2008-2015 59
Figure 13: Cardiovascular Devices, Israel, Market Share (%) of Leading Companies, 2015 60
Figure 14: Medical Device Market, Israel, Ophthalmic Devices ($m), 2008-2015 61
Figure 15: Ophthalmic Devices, Israel, Market Share (%) of Leading Companies, 2012 62
Figure 16: Medical Device Market, Israel, Drug Delivery Devices Market ($m), 2008-2015 63
Figure 17: Drug Delivery Devices Market, Israel, Market Share (%) of Leading Companies, 2008-2012 64
Figure 18: Medical Device Market, Israel, Revenue of Leading Companies ($m), 2015 65
Figure 19: Healthcare Market, Israel, Drivers and Barriers, 2016 102
Figure 20: Healthcare System, Israel, Overview of Healthcare System, 2015 104
Figure 21: Healthcare Spending, Israel, Out-of-Pocket Expenditure (%), 2008-2014 111
Figure 22: Market Access, Israel, Change in Prices of Medicines (%), 2008-2015 112
Figure 23: Market Access, Israel, Overview of Regulatory Bodies, 2016 116
Figure 24: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2008-2015 141
Figure 25: Economic Indicators, Israel, Gross Domestic Product per Capita ($), 2016-2020 142
Figure 26: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2008-2015 143
Figure 27: Economic Indicators, Israel, Gross Domestic Product Annual Growth (%), 2016-2020 144
Figure 28: Economic Indicators, Israel, Gross National Income per Capita ($), 2008-2015 145
Figure 29: Economic Indicators, Israel, Average Consumer Price Index, 2008-2015 146
Figure 30: Economic Indicators, Israel, Average Consumer Price Annual Change (%), 2008-2015 147
Figure 31: Economic Indicators, Israel, Currency Exchange Rate (ILS/$), 2008-2015 148
Figure 32: Economic Indicators, Israel, Foreign Direct Investment ($bn), 2008-2015 149
Figure 33: Economic Indicators, Israel, Foreign Exchange Reserves ($bn), 2008-2015 150
Figure 34: Economic Indicators, Israel, Imports of Goods and Services ($bn), 2008-2015 151
Figure 35: Economic Indicators, Israel, Exports of Goods and Services ($bn), 2008-2015 152
Figure 36: Economic Indicators, Israel, Government Structural Balance ($bn), 2008-2015 153
Figure 37: Economic Indicators, Israel, General Government Net Debt as Percentage of GDP (%), 2008-2015 154
Figure 38: Economic Indicators, Israel, Major Industries by Revenue (%), 2014 155
Figure 39: Demographics, Israel, Population (million), 2008-2015 157
Figure 40: Demographics, Israel, Population (million), 2016-2020 158
Figure 41: Demographics, Israel, Population, Urban and Rural Population Share (%), 2008-2015 159
Figure 42: Demographics, Israel, Population, Urban and Rural Population Share (%), 2014-2020 160
Figure 43: Demographics, Israel, Population Distribution by Age Group (%), 2008-2015 161
Figure 44: Demographics, Israel, Population Distribution by Age Group (%), 2016-2020 162
Figure 45: Demographics, Israel, Births (per 1,000 population), 2008-2014 163
Figure 46: Demographics, Israel, Mortality (per 1,000 population), 2008-2014 164
Figure 47: Demographics, Israel, Major Causes of Mortality, 2013 165
Figure 48: Demographics, Israel, Infant Mortality (per 1,000 live births), 2008-2015 166
Figure 49: Demographics, Israel, Immunization Rate (%), 2008-2014 168
Figure 50: Demographics, Israel, Major Causes of Male Mortality (per 100,000 population), 2013 169
Figure 51: Demographics, Israel, Major Causes of Female Mortality (per 100,000 population), 2013 170
Figure 52: Demographics, Israel, Gender Ratio (M/F), 2008-2015 172
Figure 53: Demographics, Israel, Life Expectancy at Birth (years), 2008-2015 173
Figure 54: Demographics, Israel, Life Expectancy at Birth (years), 2016-2020 174
Figure 55: Demographics, Israel, Enrollment by Level of Education (‘000), 2009-2014 176
Figure 56: Demographics, Israel, Unemployment Rate (%), 2008-2015 178
Figure 57: Demographics, Israel, Distribution of Male Employment by Occupation (%), 2014 179
Figure 58: Demographics, Israel, Distribution of Female Employment by Occupation (%), 2014 180
Figure 59: Demographics, Israel, Number of Reported Cases per Disease (per 1,000 population), 2009 181
Figure 60: Demographics, Israel, Major Diseases, Disability-Adjusted Life Years (‘000), 2012 182
Figure 61: Healthcare Infrastructure, Israel, Number of Hospital Establishments, 2008-2014 184
Figure 62: Healthcare Infrastructure, Israel, Public and Private Hospitals, 2008-2014 185
Figure 63: Healthcare Infrastructure, Israel, Type of Hospital Care, 2008-2014 186
Figure 64: Healthcare Infrastructure, Israel, Diagnostic Equipment (per million population), 2008-2015 188
Figure 65: Healthcare Infrastructure, Israel, Hospital Beds (per 1,000 population), 2008-2015 189
Figure 66: Healthcare Infrastructure, Israel, Doctors (per 1,000 population), 2008-2014 190
Figure 67: Healthcare Infrastructure, Israel, PM2.5 (µg/m3), 2008-2014 192
Figure 68: Healthcare Infrastructure, Israel, Carbon Dioxide Emissions (million metric tons), 2008-2014 193
Figure 69: Healthcare Infrastructure, Israel, Nurses (per 1,000 population), 2008-2014 194
Figure 70: Healthcare Infrastructure, Israel, Pharmacists (per 1,000 population), 2008-2014 195
Figure 71: Healthcare Infrastructure, Israel, Dentists (per 1,000 population), 2008-2014 196
Figure 72: Healthcare Expenditure, Israel, Healthcare Expenditure as a Percentage of GDP (%), 2008-2015 197
Figure 73: Healthcare Expenditure, Israel, Public-Private Share (%), 2008-2014 198
Figure 74: Healthcare Expenditure, Israel, Primary Healthcare Expenditure by Sector (%), 2012 199
Figure 75: Healthcare Expenditure, Israel, Financing Agents (%), 2014 200
Figure 76: Healthcare Expenditure, Israel, GDP Expenditure on RandD in Sciences ($bn), 2008-2014 202
Figure 77: Healthcare Market, Israel, Opportunities and Challenges, 2016 207

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Healthcare IT Market by Product End User - Global Forecast to 2021

Healthcare IT Market by Product End User - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

Ultrasound Market by Technology, Display, Portability, Application, End User - Forecast to 2021

  • $ 7150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

EU5 Computed Tomography (CT) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Computed Tomography (CT) Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Computed Tomography (CT) Systems Market Outlook to 2022", provides key market data on the EU5 Computed ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.